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Summary
Introduction The purpose of this study was the evalu-
ation of a weight loss program in primary care settings 
with respect to the European Clinical Practice Guidelines 
for the Management of Obesity in Adults with regard to 
the long-term success of changes in body weight and 
composition.
Methods Overweight and obese patients (n = 1167) 
who underwent a standardized meal replacement-based 
weight loss program (myLINE, AENGUS, Austria) in pri-
mary care settings were included in this evaluation. Body 
composition was measured by conventional anthro-
pometry and bioelectrical impedance analysis (AKERN 
BIA101, BIACORPUS RX4000, SoftwareBodycomp Ver-
sion 8.4 Professional). Data of patients who participated 
at least 12 months in the program were analyzed retro-
spectively and compared with their baseline data.
Results After 12 months, a weight loss of 8.6 ± 7.5  kg 
(mean ± standard deviation) or 8.2 ± 7.8 % from baseline 
was seen (p < 0.001). In all, 71.9 % of all patients achieved 
a minimal weight loss of 5 %, and 18.8 % lost 15 % of 
their initial weight. In comparison with the baseline 
(35.7 ± 11.5 kg), body fat decreased to 29.6 ± 10.7 kg, which 
is 83.7 ± 18.9 % from baseline (100 %; p < 0.001). Body 
cell mass showed an absolute reduction of − 1.4 ± 2.2 kg 
(p < 0.001), although a relative increase of 1.5 ± 2.5 % 
(p < 0.001). There were no significant differences between 
male and female subjects regarding changes in weight, 
body fat, and body cell mass.
Conclusion The evaluated program complies with the 
European Clinical Practice Guidelines for Management 
of Obesity in Adults (2008), which recommend a weight 
reduction of 5–15 % from initial weight within 6 months. 
Furthermore, the data showed a significant reduction of 
body fat and a relative increase of body cell mass.
Keywords Weight loss program · Long-term effect · Pri-
mary care · Body composition · Obesity
Evaluierung eines im niedergelassenen Bereich 
durchgeführten ersatzmahlzeitenbasierten 
Adipositastherapieprogramms nach geltenden 
europäischen Richtlinien zur Behandlung von 
Adipositas bei Erwachsenen
Zusammenfassung
Ziel Evaluierung eines Adipositastherapieprogramms 
bezüglich der Konformität mit den European Clinical 
Practice Guidelines (2008) für das Management von 
Adipositas bei Erwachsenen und Kontrolle des Lang-
zeiterfolgs anhand des Verlaufs von Körpergewicht und 
-zusammensetzung.
Methodik Übergewichtige Teilnehmer (n = 1167) 
eines standardisierten, ersatzmahlzeitenbasierten Adi-
positastherapieprogramms (myLINE, AENGUS, Austria) 
wurden in österreichischen Arztpraxen ins Programm 
eingeschlossen. Die Körperzusammensetzung wurde 
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mittels konventioneller Anthropometrie und Bioelektri-
scher Impedanz Analyse (AKERN BIA101, BIACORPUS 
RX4000, Software Bodycomp Version 8.4) erhoben. Die 
Daten jener Patienten, die zumindest 12 Monate im Pro-
gramm waren, wurden retrospektiv analysiert und mit 
deren Ausgangsdaten verglichen.
Ergebnisse Nach 12 Monaten war ein Gewichts-
verlust von 8,6 ± 7,5  kg (mean ± SD) bzw. 8,2 ± 7,8 % 
(p < 0,001) zu sehen. 71,9 % aller Teilnehmer erzielten 
eine Gewichtsreduktion von mindestens 5 und 18,8 % 
eine Gewichtsreduktion von 15 % ihres Ausgangsge-
wichts. Im Vergleich zum Körperfettanteil zu Programm-
start (35,7 ± 11,5 kg) betrug der Körperfettanteil nach 12 
Monaten 29,6 ± 10,7  kg, das sind 83,7 ± 18,9 % vom Aus-
gangswert ( = 100 %; p < 0,001). Während der 12 Monate 
kam es zu einer Abnahme der absoluten Körperzell-
masse von − 1,4 ± 2,2 kg (p < 0,001), gleichwohl nahm die 
relative Körperzellmasse um 1,5 ± 2,5 % (p < 0,001) im 
Vergleich zum Programmstart zu. Es zeigten sich keine 
signifikanten Unterschiede zwischen den Geschlechtern 
hinsichtlich der Gewichts-, Körperfett- und Körperzell-
masseentwicklung über den Beobachtungszeitraum.
Schlussfolgerung Das evaluierte Programm ent-
spricht den European Clinical Practice Guidelines (2008) 
für die Therapie von Adipositas bei Erwachsenen, die 
eine Reduktion des Ausgangsgewichts von 5–15 % inner-
halb von 6 Monaten empfehlen. Weiters zeigten sich eine 
signifikante Verringerung des Körperfettanteils und ein 
signifikanter Anstieg der relativen Körperzellmasse.
Schlüsselwörter Gewichtsreduktionsprogram  · Lang-
zeiterfolg  · Niedergelassener Bereich  · Körperzusam-
mensetzung · Adipositas
Introduction
The current Austrian Nutrition Report shows an approxi-
mately 40 % prevalence of overweight and obesity among 
adults. Overweight is one of the most common health 
issues in Austria, as in many other European countries 
[1]. High body weight and fat are associated with an 
increased risk of cardiovascular complications, cer-
tain cancers, diabetes mellitus, Alzheimer’s disease, 
gallbladder disease, sleep apnea, osteoarthritis, renal 
disease, and musculoskeletal disorders [2–4]. A mod-
est weight loss of 5–10 % has been shown to reduce the 
risk of developing diabetes by 58 % in at-risk patients [5] 
and reduces overall risk of mortality by 20 % [6–8]. Effec-
tive weight reduction can decrease disease risk, lower 
the health service expenditure, and improve the quality 
of life in affected persons [4, 9, 10]. Studies have shown 
that structured treatment programs with regular follow-
up improve long-term weight loss and maintenance [11, 
12]. Obesity management programs at primary care level 
should underlie regular quality checks [13, 14]. However, 
there is a lack of evidence about current approaches to 
obesity management in Austrian primary care.
In view of this fact, the present study evaluated the 
12-month data based on the evaluation of changes in 
bodyweight and composition during the intervention 
and the follow-up phase of a standardized weight loss 
program conducted in primary care settings, according 
to the actual European Clinical Practice Guidelines for 
the Management of Obesity in Adults [15].
Material and methods
Subjects
A random sample of 1167 overweight participants 
(female = 979, male = 188; body mass index (BMI) ≥ 25 kg/
m2) has been included in the weight loss program in 250 
Austrian primary care settings.
Data of men and women who attended the program at 
least 12 months without interruption have been analyzed, 
and their results were compared with their baseline data. 
Exclusion criteria were BMI < 25  kg/m2, diabetes melli-
tus, being pregnant or lactating, cardiovascular disease, 
other medical conditions prohibiting weight loss, sub-
stance abuse, severe psychiatric illness, and eating dis-
orders (anorexia nervosa, bulimia nervosa, binge eating 
disorder). The corresponding descriptive statistic is pre-
sented in Table 1.
Table 1 Descriptive characteristic at baseline
Men Women Significance of differencesa Total
Number 188 979 1167
Age (years) 49.2 ± 13.8 46.5 ± 13.3 n.s.b 46.9 ± 13.4
Weight (kg) 107.5 ± 16.3 89.5 ± 17.7 p < 0.001 92.3 ± 18.7
BMI (kg/m2) 34.1 ± 5.0 33.0 ± 6.3 p = 0.004 33.1 ± 6.1
Fat mass (kg) 32.4 ± 9.9 35.9 ± 11.7 p < 0.001 35.7 ± 11.5
BCM (kg) 39.1 ± 5.9 26.3 ± 3.9 p < 0.001 28.5 ± 6.5
Data are mean ± standard deviation
BMI body mass index, BCM body cell mass
aDifferences in the distributions of variables between men and women were tested by Student’s t-test for two independent samples (in case of normally distrib-
uted variables) and by Mann–Whitney U-test for two independent samples (if variables were not normally distributed)
bNot significant (p > 0.05)
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During the whole program, at regular intervals (start, 
reduction, and transition phase: every 14 days; stabiliza-
tion phase: once a month; afterward four times a year), 
the participants were measured by bioelectrical imped-
ance analysis (BIA) and conventional anthropometry 
and received individual nutritional advice from a regis-
tered dietician. In the context of individual face-to-face 
consultations, aims and treatment plans, also including 
improvement of the activity level in accordance with 
the actual recommendations, are defined. A nutrition 
and activity diary for self-reflection and a participant 
handbook for support and exercises at home are used as 
instruments of behavior therapy.
After the weight reduction, there is the possibil-
ity to participate in a follow-up program. Regular con-
trols should improve long-term weight loss and weight 
maintenance.
Meal replacement
The declaration of all products took place at the Austrian 
Federal Ministry of Health as foods intended for use in 
energy-restricted diets for weight reduction. All products 
are in accordance with the directive 96/8/EG of the Euro-
pean dietetic food regulation. Furthermore, products 
undergo regular laboratory controls and are only avail-
able in primary care units in combination with regular 
follow-up examinations [16].
Measure of body composition
The measurement of body composition was performed 
by conventional anthropometry (weight, height, waist 
circumference) and BIA (AKERN BIA 101, BIACORPUS 
RX 4000, Software Bodycomp version 8.4 professional).
Statistics
Statistical analysis was performed by SPSS for Windows 
Version 17.0 (SPSS Inc., Chicago). All results are pre-
sented as mean ± standard deviation (SD). Differences in 
the distributions of variables between men and women 
were tested by Student’s t-test for two independent 
samples (in case of normally distributed variables) and 
by Mann–Whitney U-test for two independent samples 
(if variables were not normally distributed). Compari-
son between baseline and 12 months was done using 
analysis of variance. p-Values < 0.05 were considered as 
significant.
Results
All participants who underwent the program for at least 
12 months without interruption were included in the 
evaluation. Their baseline characteristics are presented 
The procedures used in this evaluation were in accor-
dance with the Declaration of Helsinki (1964) and its 
later amendments. The study is approved and registered 
under No 2107/2013 of the ethics committee of the Medi-
cal University of Vienna. All participants gave their writ-
ten informed consent prior to their inclusion into the 
program.
Program design
The myLINE-program (www.myline.at, AENGUS, Aus-
tria) is a standardized, meal replacement-based weight 
loss program for at least 24 weeks. The diet is in accor-
dance with the latest nutritional recommendations of the 
German Nutrition Society (DGE), the Austrian Nutrition 
Society (ÖGE), the Swiss Nutrition Society (SGE), and the 
Swiss Association for Nutrition (SVE), which are called 
DACH-recommendations.
The program consists of four phases:
1. Starting phase: During the first 2 days, the participants 
use exclusively a very low-calorie diet. Five meal replace-
ments should be eaten on a regular basis every 3 h.
Total energy intake: 835  kcal/day, 60.0  g/day of pro-
tein, 15.5 g/day of fat, and 100.0 g/day of carbohydrates.
2. Reduction phase: Beginning with the third day, two out 
of three meals should be replaced by an energy-reduced 
standard diet for weight control, and one meal should be 
eaten as regular fat-reduced food.
Participants are trained in creating their meal accord-
ing to an exchange schema. The total fat content is ≤ 30 % 
of the daily energy intake. The reduction phase should be 
undertaken until the participant achieves two-thirds of 
the intended weight reduction, but at least for 10 weeks.
Total energy intake: 1000–1300 kcal/day, 50–65 g/day 
of protein (~ 20 energy percent (E%)), 34–44 g/day of fat 
(~ 30  E%), and 125–160  g/d of carbohydrates (~ 50  E%). 
For persons with a high body cell mass (BCM), the con-
tent of proteins would be individually adjusted.
3. Transitional phase: The beginning of the transitional 
phase is determined individually, but the participant 
should have performed the phase 3 for at least 10 weeks. 
In this phase, at least one meal should be replaced and the 
other two should be eaten as a fat-reduced mixed meal.
Total energy intake: 1300–1600 kcal/day, 50–65 g/day 
of protein (~ 20  E%), 34–44  g/day of fat (~ 30  E%), and 
160–200  g/day of carbohydrates (~ 50  E%). For persons 
with a high BCM, the content of proteins would be indi-
vidually adjusted.
4. Stabilization phase: Due to the acquired knowledge 
on how to arrange their meals correctly and how to 
adjust their energy intake to their daily requirements, the 
participants should maintain their weight without meal 
replacements. In this phase, they should eat three meals 
per day regularly.
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initial body weight as adequate to reduce the health risk 
in obese patients [15, 19]. Additionally, Hauner et al. [13] 
defined success for obesity therapy programs in primary 
care as follows: at least 50 % of the participants have to 
lose 5 % of their initial weight, and 20 % should achieve 
a weight reduction of 10 % from baseline. For the defini-
tion of long-term success, there exists no uniform defini-
tion. The Institute of Medicine defines long-term success 
as an achieved body weight at least 5 % below the initial 
weight or a BMI at least one unit below the baseline BMI 
1 year after weight reduction [20]. Wing and Hill [21] pro-
posed that successful weight loss maintainers are defined 
as patients who initially have lost at least 10 % of their 
body weight and stabilized at least for 1 year. The Clinical 
Guidelines on Evaluation and Treatment of Overweight 
and Obesity in Adults have defined successful weight 
maintenance after weight loss as a weight regain of less 
than 3 kg in 2 years [22].
In the case of the evaluated program, the average 
weight reduction was 8.6  kg or 8.2 % after 12 months. 
Compared with the data of Franz et al. [23], which sys-
tematically reviewed the long-term effect of 80 differ-
ent medical weight loss interventions, the present data 
are well within or even above the reported range. In the 
current study, approximately three-quarter of the par-
ticipants reached a weight reduction of 5 %, and 40 %, a 
reduction of 10 %. Due to the program structure, it is sub-
sequently not possible to provide an accurate retention 
rate, as participants may achieve their weight goal before 
12 months or some may stop the program after a shorter 
period than 12 months and restart it again afterward, 
which can therefore not be defined as dropouts.
BMI after 12 months was, on average, 3 units lower 
compared with the BMI at the beginning of the program. 
These results are in accordance with the criteria referred 
earlier in the text. Long-term weight loss was greater than 
weight loss observed in other primary care trials [24–27], 
with the exception of a study involving morbidly obese 
patients who were treated with intensive group lifestyle 
modification and weight loss medications [28].
Reduction in body fat and preservation of lean body 
mass are crucial for beneficial metabolic effects and pre-
vention of weight regain and sarcopenic obesity due to 
in Table 1. Men showed a higher weight (p < 0.001), BMI 
(p < 0.001) and muscle mass (p < 0.001) and lower fat 
mass (p < 0.001) in comparison with women at baseline, 
although there were no significant differences between 
male and female in the development of weight, body fat, 
and BCM during the observation period.
After 12 months, a weight loss of 8.6 ± 7.5 kg (mean ± SD) 
or 8.2 ± 7.8 % was seen (p < 0.001; Table 2), which corre-
sponds to a loss of excess weight of 28 %. In all, 71.9 % 
of all participants reached a minimal weight loss of 5 %, 
40 % lost 10 %, and 18.8 % of the participants lost 15 % of 
their initial weight. These findings correspond to a mean 
BMI reduction of 3.1 ± 2.7 units (p < 0.001; Table 2). A total 
of 81.5 % of the participants achieved a minimum BMI 
reduction of 1 unit after 12 months. Body fat decreased 
by 6.2 ± 5.9  kg (p < 0.001; Table  2). In comparison with 
baseline data of 35.7 ± 11.5  kg, body fat decreased to 
29.6 ± 10.7 kg after 12 months, which is 83.7 ± 18.9 % from 
baseline (100 %; p < 0.001; Table  2). With regard to the 
time course of weight loss, we could obtain data from a 
smaller sample (70 from 1167 patients), which showed 
that the maximum body weight and body fat reduction 
was achieved after 6 months. Furthermore, BCM showed 
an absolute decrease of − 1.4 ± 2.2  kg (p < 0.001), but a 
relative increase of 1.5 ± 2.5 % (p < 0.001) after 12 months 
(Table 2).
Discussion
Successful weight reduction and weight maintenance 
after weight reduction is the greatest challenge in the 
therapy of obesity. Effective methods to achieve this 
ambitious goal, especially in primary care, are required 
[17, 18]. In this study, a meal replacement-based weight 
management program was evaluated according to the 
actual European Clinical Practice Guidelines for the Man-
agement of Obesity in Adults, with respect to the long-
term success regarding changes in body weight and body 
composition. As defined by the European Guidelines, a 
weight reduction of 5–15 % within 6 months or 0.5–1.0 kg 
per week is realistic and desirable [15]. International 
committees consider a weight reduction of 5–10 % of the 
Table 2 Body composition data from baseline to 12 months
N = 1167 Baseline 12 months Differences between BL and 
12 months
Significance of differencesa
Weight (kg) 92.3 ± 18.7 83.7 ± 16.8 − 8.6 ± 7.5 p < 0.001
BMI (kg/m²) 33.1 ± 6.1 30.0 ± 5.5 − 3.1 ± 2.7 p < 0.001
Fat Mass (kg) 35.7 ± 11.5 29.6 ± 10.7 − 6.2 ± 5.9 p < 0.001
Fat Mass (%) 38.2 ± 6.9 34.7 ± 7.3 − 3.5 ± 3.9 p < 0.001
BCM (kg) 28.5 ± 6.5 27.1 ± 6.1 − 1.4 ± 2.2 p < 0.001
BCM (%) 31.2 ± 4.8 32.7 ± 5.0 1.5 ± 2.5 p < 0.001
Data are mean ± standard deviation
BL baseline, BMI body mass index, BCM body cell mass
aComparison between baseline and 12 months was calculated using analysis of variance
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loss of BCM [18]. White adipose tissue is recognized as an 
active endocrine tissue that secretes numerous immuno-
modulatory factors that play major roles in regulation of 
human metabolic and vascular biology, and is therefore 
significantly involved in the pathogenesis of the meta-
bolic syndrome [29]. The collected data showed a body 
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A possible explanation for the success of the exam-
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Conclusion
The evaluated program complies with national and inter-
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regular body composition measurements during weight 
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